×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FLGT – fulgent genetics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FLGT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/27
04:05 am
flgt
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock [Seeking Alpha]
Low
Report
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock [Seeking Alpha]
1/13
05:44 am
flgt
Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/12
11:02 am
flgt
Fulgent Genetics to Acquire Bako Diagnostics Assets and StrataDx for $55.5 Million [Los Angeles Times (CA)]
Low
Report
Fulgent Genetics to Acquire Bako Diagnostics Assets and StrataDx for $55.5 Million [Los Angeles Times (CA)]
12/23
02:16 am
flgt
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx [Yahoo! Finance]
Low
Report
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx [Yahoo! Finance]
12/22
04:29 pm
flgt
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx [Yahoo! Finance]
Low
Report
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx [Yahoo! Finance]
12/22
04:10 pm
flgt
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Low
Report
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
12/2
08:09 am
flgt
Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating [Seeking Alpha]
Low
Report
Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating [Seeking Alpha]
11/14
07:22 am
flgt
Fulgent Genetics (NASDAQ:FLGT) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Fulgent Genetics (NASDAQ:FLGT) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
11/14
07:22 am
Reiterates
Outperform
Outperform
Raymond James Financial, Inc.
Low
Report
-1.7%
Date
Time
Symbol
Headline
Impact
1/28
05:02 pm
flgt
Form 4 Fulgent Genetics, Inc. For: Jan 26 Filed by: Kim Paul
Low
Report
Form 4 Fulgent Genetics, Inc. For: Jan 26 Filed by: Kim Paul
1/28
05:02 pm
flgt
Form 4 Fulgent Genetics, Inc. For: Jan 26 Filed by: Xie Jian
Low
Report
Form 4 Fulgent Genetics, Inc. For: Jan 26 Filed by: Xie Jian
1/28
05:02 pm
flgt
Form 4 Fulgent Genetics, Inc. For: Jan 26 Filed by: Gao Hanlin
Low
Report
Form 4 Fulgent Genetics, Inc. For: Jan 26 Filed by: Gao Hanlin
12/22
04:11 pm
flgt
Form 8-K Fulgent Genetics, Inc. For: Dec 20
Low
Report
Form 8-K Fulgent Genetics, Inc. For: Dec 20
12/3
05:05 pm
flgt
Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Xie Jian
Low
Report
Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Xie Jian
12/3
05:05 pm
flgt
Form 4 Fulgent Genetics, Inc. For: Dec 01 Filed by: Kim Paul
Low
Report
Form 4 Fulgent Genetics, Inc. For: Dec 01 Filed by: Kim Paul
12/3
05:04 pm
flgt
Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Gao Hanlin
Low
Report
Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Gao Hanlin
12/1
09:15 pm
flgt
Form 4 Fulgent Genetics, Inc. For: Nov 28 Filed by: Xie Jian
Low
Report
Form 4 Fulgent Genetics, Inc. For: Nov 28 Filed by: Xie Jian
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/4
Q3/2019 9/30/2019 EPS 0.140 ZacksConsensus 0.010 ActVsEst 0.130 - Beat
38.4%
8/5 Fulgent Genetics Reports Second Quarter 2019 Financial Results 27.5%
11/8 Form 10-Q Fulgent Genetics, Inc. For: Sep 30 26.6%
3/17 Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19) 16.1%
2/14 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.6%
6/3 Form 4 Fulgent Genetics, Inc. For: May 30 Filed by: BOLGER JOHN C 8.3%
4/29 Fulgent Genetics Inc (NASDAQ: FLGT) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 7.1%
3/13 Form 10-K Fulgent Genetics, Inc. For: Dec 31 6.7%
12/22 Is KVH Industries, Inc. (KVHI) A Good Stock To Buy? [Yahoo! Finance News] 6.4%
8/5 Form 8-K Fulgent Genetics, Inc. For: Aug 01 3.9%
8/5 Fulgent Genetics Reports Second Quarter 2019 Financial Results 27.5%
11/8 Form 10-Q Fulgent Genetics, Inc. For: Sep 30 26.6%
3/17 Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19) 16.1%
2/14 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.6%
6/3 Form 4 Fulgent Genetics, Inc. For: May 30 Filed by: BOLGER JOHN C 8.3%
4/29 Fulgent Genetics Inc (NASDAQ: FLGT) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 7.1%
3/13 Form 10-K Fulgent Genetics, Inc. For: Dec 31 6.7%
12/22 Is KVH Industries, Inc. (KVHI) A Good Stock To Buy? [Yahoo! Finance News] 6.4%
8/5 Form 8-K Fulgent Genetics, Inc. For: Aug 01 3.9%
TOP News Decliners
3/10
Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results
-34.1%
11/13 Fulgent Genetics Announces Proposed Public Offering of Common Stock -18.5%
3/12 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -17.7%
2/21 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -11.3%
5/7 Q1/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.060 ActVsEst 0.000 - In-Line -10.1%
11/5 Form 4 Fulgent Genetics, Inc. For: Nov 01 Filed by: KIM PAUL -8.3%
10/8 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -7.6%
8/7 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.3%
2/20 Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020 -7.1%
8/12 Form S-3 Fulgent Genetics, Inc. -6.4%
11/13 Fulgent Genetics Announces Proposed Public Offering of Common Stock -18.5%
3/12 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -17.7%
2/21 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -11.3%
5/7 Q1/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.060 ActVsEst 0.000 - In-Line -10.1%
11/5 Form 4 Fulgent Genetics, Inc. For: Nov 01 Filed by: KIM PAUL -8.3%
10/8 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -7.6%
8/7 Fulgent Genetics Inc (NASDAQ: FLGT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.3%
2/20 Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020 -7.1%
8/12 Form S-3 Fulgent Genetics, Inc. -6.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: